Inhibition of Nicotine Metabolism by Cannabidiol (CBD) and 7-Hydroxycannabidiol (7-OH-CBD)CHEMICAL RESEARCH IN TOXICOLOGYIF3.82023-01-1014OAAI
Cannabinoids and drug metabolizing enzymes: potential for drug-drug interactions and implications for drug safety and efficacyEXPERT REVIEW OF CLINICAL PHARMACOLOGYIF32022-12-0116OA
Inhibition of the Aromatase Enzyme by Exemestane Cysteine ConjugatesMOLECULAR PHARMACOLOGYIF32022-11-012OAAI
Impact of Genetic Variants in the Nicotine Metabolism Pathway on Nicotine Metabolite Levels in SmokersCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42022-10-174OA
Influence of Glutathione-S-Transferase A1*B Allele on the Metabolism of the Aromatase Inhibitor, Exemestane, in Human Liver Cytosols and in Patients Treated With ExemestaneJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82022-09-014OAAI
Inhibitory Effects of Major Cannabinoids and their Metabolites on Oxazepam MetabolismFASEB JOURNALIF4.22022-05-130PRE
Inhibition of Morphine Metabolism by Major Cannabinoids and their MetabolitesFASEB JOURNALIF4.22022-05-130PRE
Altered Metabolism of Polycyclic Aromatic Hydrocarbons by UDP-Glycosyltransferase 3A2 Missense VariantsCHEMICAL RESEARCH IN TOXICOLOGYIF3.82020-09-303OAAI
Assessment of CYP2A6 and CYP2C19 Genetic Variation on Cotinine-N-Oxide Formation and their Potential Effect on the Nicotine Metabolic Ratio (NMR)FASEB JOURNALIF4.22020-04-180OA
Cytosolic glutathione-S-transferase A1 (GSTA1) plays a primary role in the metabolic clearance of the aromatase inhibitor, ExemestaneFASEB JOURNALIF4.22020-04-180OA
The Novel CYP2A6 Inhibitor, DLCI-1, Decreases Nicotine Self-Administration in MiceJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82020-01-0117OAAI
Potential Regulation of UGT2B10 and UGT2B7 by miR-485-5p in Human LiverMOLECULAR PHARMACOLOGYIF32019-12-019OAAI
Prominent Stereoselectivity of NNAL Glucuronidation in Upper Aerodigestive Tract TissuesCHEMICAL RESEARCH IN TOXICOLOGYIF3.82019-07-166OAAI
Regulation of UGT2A1 by miR-196a-5p and miR-196b-5pJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82019-05-0118OAAI
Nicotine-N′-Oxidation by Flavin Monooxygenase EnzymesCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42019-02-0419OA
Identification of the 4-Position of 3-Alkynyl and 3-Heteroaromatic Substituted Pyridine Methanamines as a Key Modification Site Eliciting Increased Potency and Enhanced Selectivity for Cytochrome P-450 2A6 InhibitionJOURNAL OF MEDICINAL CHEMISTRYIF6.82018-07-119OAAI
Carbonyl reduction of NNK by recombinant human lung enzymes: identification of HSD17β12 as the reductase important in (R)-NNAL formation in human lungCARCINOGENESISIF2.92018-05-1713OAAI
Regulation of UGT2B Expression and Activity by miR-216b-5p in Liver Cancer Cell LinesJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82016-10-0141OAAI
Localization of CYP86B1 in the outer envelope of chloroplastsPLANT AND CELL PHYSIOLOGYIF42001-08-1537OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项